HeimGEHC • NASDAQ
GE HealthCare Technologies Inc
84,76 $
13. jan., 04:32:03 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
HlutabréfSkráð hlutabréf í BandaríkinHöfuðstöðvar: Bandaríkin
Við síðustu lokun
86,26 $
Dagbil
84,40 $ - 86,07 $
Árabil
71,31 $ - 94,50 $
Markaðsvirði
38,72 ma. USD
Meðalmagn
2,94 m.
V/H-hlutf.
23,21
A/V-hlutfall
0,17%
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD)sep. 2024Breyting á/á
Tekjur
4,86 ma.0,85%
Rekstrarkostnaður
1,24 ma.3,67%
Nettótekjur
470,00 m.25,33%
Hagnaðarhlutfall
9,6624,16%
Hagnaður á hvern hlut
1,1415,15%
EBITDA
924,00 m.4,05%
Virkt skatthlutfall
25,57%
Heildareignir
Heildarskuldir
(USD)sep. 2024Breyting á/á
Reiðufé og skammtímafjárfestingar
3,55 ma.47,43%
Heildareignir
33,86 ma.4,55%
Heildarskuldir
25,34 ma.1,05%
Eigið fé alls
8,51 ma.
Útistandandi hlutabréf
456,87 m.
Eiginfjárgengi
4,74
Arðsemi eigna
5,94%
Ávöxtun eigin fjár
10,58%
Breyting á handbæru fé
(USD)sep. 2024Breyting á/á
Nettótekjur
470,00 m.25,33%
Handbært fé frá rekstri
Reiðufé frá fjárfestingum
Reiðufé frá fjármögnun
Breyting á handbæru fé
Frjálst peningaflæði
Um
GE Healthcare Technologies, Inc, organized in Delaware and headquartered in Chicago, Illinois, focuses on health technology. The company, which stylizes its own name as GE HealthCare, operates 4 divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals. The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition. The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Framkvæmdastjóri
Stofnsett
1994
Starfsfólk
51.000
Leit
Hreinsa leit
Loka leit
Google forrit
Aðalvalmynd